Liquid biopsy and minimal residual disease - latest advances and implications for cure.
Pantel K, Alix-Panabières C.
Nat Rev Clin Oncol. 2019 Jul;16(7):409-424. doi: 10.1038/s41571-019-0187-3.
Minimal residual disease detection in lymphoma: methods, procedures and clinical significance.
Zhang S, Wang X, Yang Z, Ding M, Zhang M, Young KH, Zhang X.
Front Immunol. 2024 Aug 12;15:1430070. doi: 10.3389/fimmu.2024.1430070. eCollection 2024.
Minimal residual disease in chronic lymphocytic leukaemia.
García Vela JA, García Marco JA.
Med Clin (Barc). 2018 Feb 23;150(4):144-149. doi: 10.1016/j.medcli.2017.06.067. Epub 2017 Aug 31.
Minimal Residual Disease in Acute Myeloid Leukemia.
Gomez-Arteaga A, Guzman ML.
Adv Exp Med Biol. 2018;1100:111-125. doi: 10.1007/978-3-319-97746-1_7.
Minimal Residual Disease in Acute Myeloid Leukemia.
Sung PJ, Luger SM.
Curr Treat Options Oncol. 2017 Jan;18(1):1. doi: 10.1007/s11864-017-0447-3.
Minimal residual disease in multiple myeloma: use of magnetic resonance imaging.
Hillengass J, Merz M, Delorme S.
Semin Hematol. 2018 Jan;55(1):19-21. doi: 10.1053/j.seminhematol.2018.02.001. Epub 2018 Feb 12.
Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry.
Fuda F, Chen W.
Curr Hematol Malig Rep. 2018 Dec;13(6):455-466. doi: 10.1007/s11899-018-0479-1.
Minimal Residual Disease Detection by Flow Cytometry in Multiple Myeloma: Why and How?
Roshal M.
Semin Hematol. 2018 Jan;55(1):4-12. doi: 10.1053/j.seminhematol.2018.02.011. Epub 2018 Mar 9.
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?
Al-Sawaf O, Seymour JF, Kater AP, Fischer K.
Hematol Oncol Clin North Am. 2021 Aug;35(4):775-791. doi: 10.1016/j.hoc.2021.03.007. Epub 2021 May 15.
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia.
Choi JK, Mead PE.
Clin Lab Med. 2023 Mar;43(1):115-125. doi: 10.1016/j.cll.2022.09.022.
